ESC 365 - State of the Art: genomics, inflammation and cardiovascular disease

ESC Premium Access

State of the Art: genomics, inflammation and cardiovascular disease

Session: Inflammation and cardiovascular disease: the emerging role of 'omics'

Topic: Epidemiology, lipids

Speaker: Professor A. Hingorani (London, GB)

Event: ESC Congress 2017

Congress Presentation

About the speaker

Professor Aroon Hingorani

London (United Kingdom of Great Britain & Northern Ireland)

2 presentations

0 follower

4 more presentations in this session

The association of physical activity with plasma lipoproteins and inflammation measured by NMR -metabolomics: evidence from the china kadoorie biobank study

Speaker: Miss Y. Pang (Oxford, GB)

The soluble IL6 receptor as a predictor for early cardiovascular events

Speaker: Doctor L. Ziegler (Stockholm, SE)

Identification of STXBP2 as a novel susceptibility locus for myocardial infarction in Japanese individuals by an exome-wide association study

Speaker: Professor K. Kato (Tsu, JP)

Inflammatory processes in cardiovascular disease: a route to personalised medicine?

Speaker: Doctor P. Ridker (Boston, US)

Access the full session

Inflammation and cardiovascular disease: the emerging role of 'omics'

Speakers: Professor A. Hingorani, Miss Y. Pang, Doctor L. Ziegler, Professor K. Kato, Doctor P. Ridker

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

Related content

Open Access

Integrating EPA based therapy in the management of residual risk.

29 August 2021

Open Access

How the new guidance will impact the treatment of elderly atrial fibrillation patients in clinical practice.

28 August 2021

Open Access

What is new in the 2021 EHRA Practical Guide on the use of NOACs in patients with atrial fibrillation.

28 August 2021

ESC 365 is supported by